Evidence map›Paper›PMID 38912333›Full record

ReviewDose-response : a publication of International Hormesis Society

A Review of Artificial Intelligence Application for Radiotherapy.

Guoping Shan, Shunfei Yu, Zhongjun Lai, Zhiqiang Xuan, Jie Zhang, Binbing Wang, Yun Ge

Abstract readReview
In one paragraph

Review in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Guoping ShanSchool of Electronic Science and Engineering, Nanjing University, Nanjing, China.
Shunfei YuZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Zhongjun LaiZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Zhiqiang XuanZhejiang Provincial Center for Disease Control and Prevention, Hangzhou, China.
Jie ZhangZhejiang Cancer Hospital, Hangzhou, China.ORCID https://orcid.org/0000-0002-0817-0464
Binbing WangZhejiang Cancer Hospital, Hangzhou, China.
Yun GeSchool of Electronic Science and Engineering, Nanjing University, Nanjing, China.ORCID https://orcid.org/0000-0003-1788-3295

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: Artificial intelligence (AI) is a technique which tries to think like humans and mimic human behaviors. It has been considered as an alternative in a lot of human-dependent steps in radiotherapy (RT), since the human participation is a principal uncertainty source in RT. The aim of this work is to provide a systematic summary of the current literature on AI application for RT, and to clarify its role for RT practice in terms of clinical views. Materials and Methods: A systematic literature search of PubMed and Google Scholar was performed to identify original articles involving the AI applications in RT from the inception to 2022. Studies were included if they reported original data and explored the clinical applications of AI in RT. Results: The selected studies were categorized into three aspects of RT: organ and lesion segmentation, treatment planning and quality assurance. For each aspect, this review discussed how these AI tools could be involved in the RT protocol. Conclusions: Our study revealed that AI was a potential alternative for the human-dependent steps in the complex process of RT.

Indexed as

artificial intelligenceautomated treatment planningauto-segmentationquality assuranceradiotherapy

Identifiers

PMID38912333
PMCPMC11193352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.